Global Raloxifene Market Research Report 2022

Raloxifene, primarily used to prevent and treat osteoporosis in postmenopausal women, has been shown to significantly reduce the incidence of vertebral fractures, but the reduction in hip fractures has not been demonstrated.When deciding on the use of raloxifene or other treatments (including estrogen) for postmenopausal women, consideration should be given to menopausal symptoms, effects on uterine and breast tissue, and cardiovascular risk and beneficial effects.
Due to the COVID-19 pandemic, the global Raloxifene market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Raloxifene market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Raloxifene landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Original Drugs accounting for % of the Raloxifene global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Raloxifene include Pharmascience (Joddes Limited), Pd Rx Pharmaceuticals, Lilly, Liberty Pharma, Aurobindo Pharma, Apotex Corporation, Amneal Pharmaceuticals, Actavis (TEVA ) and Jiangsu Hengrui Pharmaceutical. etc. In terms of revenue, the global 3 largest players have a % market share of Raloxifene in 2021.
This report focuses on Raloxifene volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Raloxifene market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Raloxifene Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pharmascience (Joddes Limited)
Pd Rx Pharmaceuticals
Lilly
Liberty Pharma
Aurobindo Pharma
Apotex Corporation
Amneal Pharmaceuticals
Actavis (TEVA )
Jiangsu Hengrui Pharmaceutical